Discover

XERS
Xeris Biopharma Holdings, Inc.
8.34
7 x 8.34
8 x 8.35
bid
ask
+
0.35
4.37%
01:41 PM
timesize
Ytd6.23%
1y15.82%
7.97
day range
8.35
5.25
52 week range
10.08
Open7.99Prev Close7.99Low7.97High8.35Mkt Cap1.44B
Vol904.70KAvg Vol1.85MEPS-0.11P/E-78.36Forward P/E20.33
Beta0.66Short Ratio4.30Inst. Own61.36%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg7.66200-d Avg7.051yr Est11.29

XERS News

Xeris Biopharma Q2 Earnings Call Highlights
marketbeat.com
Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma NASDAQ: XERS reported second-quarter total revenue of $92.1 million, up 29% from a y

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript
seekingalpha.com
Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics
zacks.com
Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the q

Xeris Biopharma Reports Second Quarter 2026 Financial Results
businesswire.com
Xeris Biopharma Reports Second Quarter 2026 Financial Results

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu

Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
gurufocus.com
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to

Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
businesswire.com
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu

Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?
zacks.com
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?

Xeris Biopharma (XERS) was a big mover last session on higher-than-average trading volume. The lates

CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
gurufocus.com
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Please replace the release issued earlier today with the following corrected version that provides a

CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CHICAGO--(BUSINESS WIRE)-- #GvokeHypoPen--Please replace the release issued earlier today with the f

Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CHICAGO--(BUSINESS WIRE)-- #GvokeHypoPen--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-grow

Xeris Announces Updates to Its Board of Directors
businesswire.com
Xeris Announces Updates to Its Board of Directors

CHICAGO--(BUSINESS WIRE)--Xeris Announces Updates to Its Board of Directors.

Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS®
businesswire.com
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent C

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdin

Xeris Biopharma Announces Private Exchange of Convertible Notes
gurufocus.com
Xeris Biopharma Announces Private Exchange of Convertible Notes

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to

Xeris Biopharma Announces Private Exchange of Convertible Notes
businesswire.com
Xeris Biopharma Announces Private Exchange of Convertible Notes

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
seekingalpha.com
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right

Xeris Biopharma has delivered another year of significant revenue growth, signaling a pivotal moment

Xeris Biopharma Q1 Earnings Call Highlights
marketbeat.com
Xeris Biopharma Q1 Earnings Call Highlights

Xeris Biopharma NASDAQ: XERS reported a sharp increase in first-quarter 2026 revenue and raised the

Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript
seekingalpha.com
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the q

Xeris Biopharma Reports First Quarter 2026 Financial Results
businesswire.com
Xeris Biopharma Reports First Quarter 2026 Financial Results

CHICAGO--(BUSINESS WIRE)--XERIS BIOPHARMA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS.

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of “Moderate Buy” from Analysts
defenseworld.net
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of “Moderate Buy” from Analysts

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS - Get Free Report) has earned an average rating of "Mod

Earnings Scheduled For March 2, 2026
benzinga.com
Earnings Scheduled For March 2, 2026

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Ma

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For March 6, 2025

benzinga.com
Earnings Scheduled For March 6, 2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Earnings Scheduled For March 8, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earn

benzinga.com
Earnings Scheduled For November 9, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

benzinga.com
121 Stocks That Hit Their 52-Week Low

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12

benzinga.com
Earnings Scheduled For August 10, 2022

  Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for i

benzinga.com
Earnings Scheduled For May 11, 2022

  Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn

benzinga.com
Earnings Scheduled For August 5, 2021

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q

benzinga.com
Earnings Scheduled For May 13, 2021

  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    Monday morning saw 558 companies set new 52-week highs.

benzinga.com
71 Biggest Movers From Friday

Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday afte

benzinga.com
46 Stocks Moving In Friday's Mid-Day Session

Gainers Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) shares jumped 98.40% to $2.5201 after the

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

Stocks That Hit 52-Week Lows On Tuesday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

Stocks That Hit 52-Week Lows On Tuesday

benzinga.com
Stocks Which Set New 52-Week High Yesterday, September 12

Stocks Which Set New 52-Week High Yesterday, September 12

benzinga.com
Stocks Which Set New 52-Week High Yesterday, September 11th

Stocks Which Set New 52-Week High Yesterday, September 11th

benzinga.com
58 Biggest Movers From Yesterday

58 Biggest Movers From Yesterday